Obstetrics, gynecology, andrology, sexual and reproductive health

Gynecology

PubMed Free Full Text

Uterine fibroids

 

Australia

• Better Safer Care
  • Hysterectomy for asymptomatic fibroids

Canada

• American Journal of Obstetrics & Gynecology
  • The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids [2018]

• Canadian Agency for Drugs and Technologies in Health
  • Uterine-Preserving Interventions for the Management of Symptomatic Uterine Fibroids: A Systematic Review of Clinical and Cost-Effectiveness [2016]
  • Ulipristal Acetate (Fibristal) (5 mg Tablets): Treatment of Moderate to Severe Signs and Symptoms of Uterine Fibroids in Adult Women of Reproductive Age Who are Eligible for Surgery. The Duration of Treatment is Limited to Three Months [2013]

• CMAJ Open
  • Quality of ultrasonography reporting and factors associated with selection of imaging modality for uterine fibroids in Canada: results from a prospective cohort registry [2020]

• Current Medical Research and Opinion
  • Contemporary management of uterine fibroids: focus on emerging medical treatments [2015]

• Health Quality Ontario
  • Magnetic Resonance–Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis [2015]
  • Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis [2015]

• Society of Obstetricians and Gynaecologists of Canada
  • Medical Management of Symptomatic Uterine Leiomyomas – An Addendum [2019]
  • The Management of Uterine Leiomyomas [2015]
  • The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility [2015]

Europe

• Cardiovascular and Interventional Radiological Society of Europe
  • Uterine Artery Embolization for Symptomatic Leiomyomata [2015]

• European Medicines Agency
  • Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk [2020]

• European Menopause and Andropause Society
  • EMAS position statement: Management of uterine fibroids [2014]

• European Society of Urogenital Radiology
  • European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Leiomyomas [2018]

Germany

• Institute for Quality and Efficiency in Health Care
  • Magnetic resonance imaging-guided high-intensity focused ultrasound therapy for uterine fibroids [2017]

Germany, Switzerland, Austria

• RöFo
  • Uterine Artery Embolization (UAE) for Fibroid Treatment: Results of the 6th Radiological Gynecological Expert Meeting [2017]
  • MR-Guided Focused Ultrasound in Fibroid Treatment - Results of the 3rd Radiological-Gynecological Expert Meeting [2017]
  • Uterine Artery Embolization (UAE) for Fibroid Treatment--Results of the 5th Radiological Gynecological Expert Meeting [2015]
  • Magnetic resonance guided focused ultrasound for fibroid treatment--results of the second radiological gynecological expert meeting [2015]

International

• AAGL
  • AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of Submucous Leiomyomas [2012]

Low-resource settings

• Obstetrics and Gynecology International
  • Myomectomy during Caesarean Birth in Fibroid-Endemic, Low-Resource Settings [2013]

Spain

• International Journal of Women's Health
  • Updated approaches for management of uterine fibroids [2017]

United Kingdom

• Healthcare Improvement Scotland
  • Magnetic resonance guided focused ultrasound surgery (MRgFUS) for uterine fibroids [2015]

• Medicines and Healthcare products Regulatory Agency
  • Ulipristal acetate 5mg (Esmya): further restrictions due to risk of serious liver injury [2021]
  • Esmya (ulipristal acetate): suspension of the licence due to risk of serious liver injury [2020]
  • Esmya (ulipristal acetate) for uterine fibroids: do not initiate or re-start treatment; monitor liver function in current and recent users [2018]

• National Institute for Health and Care Excellence
  • Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids [2021]
  • Sonata system for diagnostic imaging and treatment of symptomatic uterine fibroids [2021]
  • Laparoscopic removal of uterine fibroids with power morcellation [2021]
  • Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroids [2021]
  • Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids [2019]
  • Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids [2011]
  • Uterine artery embolisation for fibroids [2010]

• Royal College of Obstetricians and Gynaecologists
  • Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk [2021]
  • Uterine Artery Embolisation in the Management of Fibroids [2013]

United States

• Agency for Healthcare Research and Quality
  • Management of Uterine Fibroids [2017]

• American College of Obstetricians and Gynecologists
  • Uterine Morcellation for Presumed Leiomyomas [2021]

• American College of Radiology
  • Radiologic Management of Uterine Leiomyomas

• American Family Physician
  • Management of Uterine Fibroids [2019]

• American Journal of Obstetrics & Gynecology
  • The Estimated Annual Cost of Uterine Leiomyomata in the United States [2012]

• American Society for Reproductive Medicine
  • Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline [2017]
  • Fibroids or Myomas

• Society for Women's Health Research
  • Uterine Fibroids: Assessing Unmet Needs from Bench to Bedside [2021]

United States, Canada

• North American Menopause Society
  • NAMS 2018 Utian Translational Science Symposium report: New Therapies for Leiomyomas: When Surgery May Not Be the Best Option [2019]

{Related topics}

• Guidelines
  • Miscarriage
  • Gynecologic ultrasound
  • Gynecologic surgery
  • Dysmenorrhea, chronic pelvic pain
  • Abnormal uterine bleeding, menorrhagia